DJIA 16,715.90 254.58 1.55%
NASDAQ 4,456.18 73.33 1.67%
S&P 500 1,954.31 27.20 1.41%
market minute promo

ULTRAGENYX PHARMAC (NASDAQ: RARE)

48.62 3.18 (7.00%)

Quote as of


company name or ticker

Recent Quotes

RARE $48.62 7.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $46.34
Previous Close $45.44
Daily Range $45.09 - $49.81
52-Week Range $32.02 - $69.77
Market Cap $1.5B
P/E Ratio -4.58
Dividend (Yield) $0.00 (0.0%)
Volume 59,318
Average Daily Volume 384,810
Current FY EPS -$2.14

Sector

Industry

ULTRAGENYX PHARMAC (RARE) Description

ULTRAGENYX PHARMAC Website: http://www.ultragenyx.com/

News & Commentary

Why Ultragenyx Pharmaceutical Inc. Stock Slumped

Ultragenyx shares aren't looking so "ultra" today after the company announced its intention to sell shares of common stock. Find out what this means for investors.

Ultragenyx Reports Data from Sialic Acid Deficiency Study - Analyst Blog

Ultragenyx Pharma Offers Interim Data from Phase 3 Extension Study of Sialic Acid ER at Int'l Congre

Ultragenyx Pharma Offers Interim Data from Phase 3 Extension Study of Sialic Acid ER at Int'l Congress of World Muscle Safety

Benzinga's Top Initiations

3 Partnerships Pushing The Pharmaceutical Sector Forward

Ultragenyx Announces Positive Results From A Long-Term Phase 1/2 Study Of KRN23 In Adult Patients Wi

Ultragenyx Announces Positive Results From A Long-Term Phase 1/2 Study Of KRN23 In Adult Patients With X-Linked Hypophosphatemia

US IPO Pricing Recap: ReWalk runs - year's 5th IPO to top 100% in first-day trading

Ultragenyx Offers Positive Interim Data from Phase 1/2 Study of Recombinant Human Beta-Glucuronidase

3 Big-Volume Biotech Stocks to Trade for Breakouts

Ultragenyx (RARE) Shares March Higher, Can It Continue? - Tale of the Tape

Ultragenyx (RARE) Shares March Higher, Can It Continue? - Tale of the Tape

Company News for August 12, 2014 - Corporate Summary

See More RARE News...